Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/05/2025 ,inter alia, to consider and approve the Audited Financial Statements ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Ltd has informed BSE that its Board of Directors will meet on Thursday, May 01, 2025. The main agenda is to consider, approve, and take on record the Audited Financial Results for the half year and full year ended March 31, 2025. The intimation is filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. The trading window for insiders will remain closed until 48 hours after the results are formally declared.
This is a routine pre-results announcement with no direct impact on the stock. Investors should watch for the actual audited FY25 numbers, which will be released after the May 1 meeting and will drive the next meaningful price movement.